Viewing Study NCT00652106


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-01-22 @ 8:42 AM
Study NCT ID: NCT00652106
Status: COMPLETED
Last Update Posted: 2008-04-03
First Post: 2008-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Sponsor: Allergan
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 190342-019T
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Therapeutic Area Head
Old Organization: Allergan, Inc.

Collaborators